Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

DataMEDS AI, Inc. (MEDS) Institutional Ownership & Insider Trading

10 institutions reported holding DataMEDS AI, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MEDSDataMEDS AI, Inc.Follow MEDS — free
Medical Distribution · Healthcare
—
Price chart with a free account
Market cap
6.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

10 institutions held 1.7% of the shares. Across filers that reported both quarters, shares held changed -97.6%.

Increased+0New+4Decreased-4Closed-9

Largest moves, shares (millions)

Barclays+0.0MTower Research Capital LLC…+0.0MFortitude Family Office+0.0MGeode Capital Management-0.7MVanguard Capital Management-0.6MVanguard Fiduciary Trust-0.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.4Mar 25+0.3Jun 25+3.8Sep 25-2.5Dec 25+0.1Mar 26-2.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26100-97.6%0449
Mar 26132+12.6%3319
Dec 25192-55.9%7724
Sep 25164—11303
Jun 2551—1203
Mar 2550—0500

DataMEDS AI, Inc. — questions

Who owns DataMEDS AI, Inc. stock?
10 institutions reported DataMEDS AI, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: JANE STREET GROUP, LLC (0.7%), GEODE CAPITAL MANAGEMENT, LLC (0.4%), VANGUARD CAPITAL MANAGEMENT LLC (0.4%).

Every figure on this page comes from DataMEDS AI, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.